Whan In Pharm Co.,Ltd. (KRX:016580)

Whan In Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59,528	43,147	45,366	36,776	64,056	36,074
Short-Term Investments	161	519	15,164	12,791	22,966	11,944
Trading Asset Securities	-	8,915	17,927	37,725	58,940	68,938
Cash & Short-Term Investments	59,689	52,581	78,457	87,292	145,962	116,956
Cash Growth	15.83%	-32.98%	-10.12%	-40.20%	24.80%	4.62%
Accounts Receivable	62,912	70,983	74,526	68,242	61,876	63,042
Other Receivables	4,476	4,644	4,340	4,021	1,243	998.83
Receivables	67,442	75,709	78,947	72,326	63,201	64,106
Inventory	90,118	72,411	54,058	37,060	32,745	32,764
Prepaid Expenses	630.31	462.1	501.07	426.78	334.39	185.05
Other Current Assets	17.14	134.39	138.51	317.02	169.72	343.61
Total Current Assets	217,896	201,297	212,101	197,422	242,412	214,355
Property, Plant & Equipment	145,562	149,218	131,211	109,854	46,869	45,822
Long-Term Investments	32,016	32,749	19,163	23,901	26,193	30,945
Other Intangible Assets	9,772	7,160	5,382	3,176	2,969	2,988
Long-Term Deferred Tax Assets	3,143	1,899	171.91	-	-	-
Other Long-Term Assets	32,466	32,362	33,159	35,002	34,715	35,431
Total Assets	440,868	424,706	401,227	369,375	353,189	329,560
Accounts Payable	19,509	22,456	18,071	11,966	9,422	8,865
Accrued Expenses	2,795	3,049	3,224	2,473	4,171	2,246
Current Portion of Leases	439.5	278.24	324.97	186.32	415.86	546.59
Current Income Taxes Payable	3,648	2,636	2,683	3,330	5,571	5,696
Other Current Liabilities	12,834	13,957	15,725	13,796	11,320	9,372
Total Current Liabilities	39,226	42,376	40,028	31,750	30,900	26,725
Long-Term Leases	320.96	135.5	307.06	63.62	1,305	1,643
Long-Term Deferred Tax Liabilities	-	-	-	368.34	1,098	2,011
Other Long-Term Liabilities	7,509	6,192	2,684	3,264	2,660	2,578
Total Liabilities	47,056	48,704	43,019	35,446	35,963	32,957
Common Stock	9,700	9,700	9,700	9,700	9,700	9,700
Additional Paid-In Capital	27,664	21,062	21,062	20,817	21,135	21,135
Retained Earnings	366,152	358,861	339,984	314,790	295,449	273,163
Treasury Stock	-6,768	-9,669	-9,669	-9,669	-9,669	-9,669
Comprehensive Income & Other	-2,935	-3,952	-2,870	-2,126	324.92	1,787
Total Common Equity	393,813	376,002	358,207	333,511	316,939	296,115
Minority Interest	-	-	-	416.75	286.26	487.35
Shareholders' Equity	393,813	376,002	358,207	333,928	317,226	296,602
Total Liabilities & Equity	440,868	424,706	401,227	369,375	353,189	329,560
Total Debt	760.47	413.74	632.03	249.94	1,721	2,190
Net Cash (Debt)	58,928	52,167	77,825	87,042	144,241	114,766
Net Cash Growth	15.49%	-32.97%	-10.59%	-39.66%	25.68%	4.12%
Net Cash Per Share	3802.68	3416.99	5097.57	5701.29	9447.84	7517.24
Filing Date Shares Outstanding	16.22	15.27	15.27	15.27	15.27	15.27
Total Common Shares Outstanding	16.22	15.27	15.27	15.27	15.27	15.27
Working Capital	178,671	158,921	172,074	165,671	211,512	187,630
Book Value Per Share	24285.02	24628.27	23462.75	21845.15	20759.68	19395.66
Tangible Book Value	384,040	368,841	352,826	330,335	313,970	293,127
Tangible Book Value Per Share	23682.40	24159.27	23110.24	21637.11	20565.20	19199.97
Land	49,677	49,677	49,572	49,726	13,536	13,536
Buildings	71,074	71,074	40,938	35,821	24,194	24,032
Machinery	26,150	25,822	22,094	18,653	10,919	9,552
Construction In Progress	699.9	103.45	18,876	7,590	4,610	4,810

Source: S&P Global Market Intelligence. Standard template. Financial Sources.